Professur für Klinische Pharmakologie

Krankenhausstraße 9
91054 Erlangen

Publications (Download BibTeX)

Go to first page Go to previous page 1 of 2 Go to next page Go to last page

Taghikhani, E.P., Maas, R., Fromm, M., & König, J. (2019). The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine. PLoS ONE, 14(3).
Geßner, A., Mieth, M., Maas, R., & Fromm, M. (2019). Simultaneous quantification of 10 endogenous biomarkers of cardiovascular diseases and renal dysfunction in small volume plasma samples by LC-MS/MS. In NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Stuttgart, GERMANY: NEW YORK: SPRINGER.
Geßner, A., Mieth, M., Auge, D., Chafai, A., Müller, F., Fromm, M., & Maas, R. (2019). Establishment of reference values for the lysine acetylation marker N ɛ-acetyllysine in small volume human plasma samples by a multi-target LC–MS/MS method. Amino Acids.
Jarzebska, N., Georgi, S., Jabs, N., Brilloff, S., Maas, R., Rodionov, R.N.,... Weiss, N. (2019). Kidney and liver are the main organs of expression of a key metabolic enzyme alanine:glyoxylate aminotransferase 2 in humans. Atherosclerosis Supplements.
Dormann, H., Maas, R., Eickhoff, C., Mueller, U., Schulz, M., Brell, D., & Thuermann, P.A. (2018). Standardized national medication plan : The pilot projects MetropolMediplan 2016, model region Erfurt, and PRIMA. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 61(9), 1093-1102.
Plank-Kiegele, B., Bürkle, T., Müller, F., Patapovas, A., Sonst, A., Pfistermeister, B.,... Maas, R. (2017). Data requirements for the correct identification of medication errors and adverse drug events in patients presenting at an emergency department. Methods of Information in Medicine, 56(4), 276-282.
Chafai, A., Fromm, M., König, J., & Maas, R. (2017). The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B. Scientific Reports, 7(1).
Maas, R., Xanthakis, V., Göen, T., Müller, J., Schwedhelm, E., Boeger, R.H., & Vasan, R.S. (2017). Plasma Nitrate and Incidence of Cardiovascular Disease and All-Cause Mortality in the Community: The Framingham Offspring Study. Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 6(11).
Rodionov, R.N., Burdin, D., Brilloff, S., Todorov, V., Jarzebska, N., Martens-Lobenhoffer, J.,... Weiss, N. (2017). Transgenic Overexpression of Alanine-glyoxylate Aminotransferase 2 in Mice Lowers Asymmetric Dimethylarginine and Improves Vasomotor Function.
Pfistermeister, B., Tuemena, T., Gassmann, K.-G., Maas, R., & Fromm, M. (2017). Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients. PLoS ONE, 12(2).
Pohl-Dernick, K., Meier, F., Maas, R., Schöffski, O., & Emmert, M. (2016). Potentially inappropriate medication in the elderly in Germany: an economic appraisal of the PRISCUS list. Bmc Health Services Research, 16(109).
Burdin, D.V., Kolobov, A.A., Brocker, C., Soshnev, A.A., Samusik, N., Demyanov, A.V.,... Rodionov, R.N. (2016). Diabetes-linked transcription factor HNF4? regulates metabolism of endogenous methylarginines and ?-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2. Scientific Reports, 6, 35503.
Schnabel, R.B., Maas, R., Wang, N., Yin, X., Larson, M.G., Levy, D.,... Benjamin, E.J. (2016). Asymmetric dimethylarginine, related arginine derivatives, and incident atrial fibrillation. American Heart Journal, 176, 100-6.
Rodionov, R.N., Oppici, E., Martens-Lobenhoffer, J., Jarzebska, N., Brilloff, S., Burdin, D.,... Bode-Boeger, S.M. (2016). A Novel Pathway for Metabolism of the Cardiovascular Risk Factor Homoarginine by alanine:glyoxylate aminotransferase 2. Scientific Reports, 6, 35277.
Pfistermeister, B., Sedlmayr, B., Patapovas, A., Suttner, G., Tektas, O., Tarkhov, A.,... Maas, R. (2016). Development of a Standardized Rating Tool for Drug Alerts to Reduce Information Overload. Methods of Information in Medicine, 55(6), 507-515.
Schlesinger, S., Sonntag, S.R., Lieb, W., & Maas, R. (2016). Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies. PLoS ONE, 11(11), e0165811.
Schächtele, S., Tuemena, T., Gassmann, K.-G., Fromm, M., & Maas, R. (2016). Co-Prescription of QT-Interval Prolonging Drugs: An Analysis in a Large Cohort of Geriatric Patients. PLoS ONE, 11(5), e0155649.
Meier, F., Maas, R., Sonst, A., Patapovas, A., Müller, F., Plank-Kiegele, B.,... Dormann, H. (2015). Adverse drug events in patients admitted to an emergency department: an analysis of direct costs. Pharmacoepidemiology and Drug Safety, 24(2), 176-186.
Ringel, R., & Maas, R. (2015). Dental procedures in patients treated with antiplatelet or oral anticoagulation therapy - an anonymous survey. Gerodontology.

Last updated on 2019-24-04 at 10:27